ELAVL1 and cancer: HuR-ARE interaction [1, 4–6] contributes to carcinogenesis by stabilizing the mRNAs of oncogenes [7, 12, 15, 18, 19], thus, finding inhibitors of HuR-ARE interaction could contribute to the development of new cancer therapies [20, 22].